Relationship between tear eotaxin-2 and MMP-9 with ocular allergy and corneal topography in keratoconus patients

[1]  S. Jacob,et al.  Keratoconus Progression in Patients With Allergy and Elevated Surface Matrix Metalloproteinase 9 Point-of-Care Test , 2017, Eye & contact lens.

[2]  M. Rajabi,et al.  Effect of Allergic Diseases on Keratoconus Severity , 2017, Ocular immunology and inflammation.

[3]  P. Gogolák,et al.  Scheimpflug Imaging Parameters Associated with Tear Mediators and Bronchial Asthma in Keratoconus , 2016, Journal of ophthalmology.

[4]  S. Shoar,et al.  Characteristics and associations of keratoconus patients. , 2015, Contact lens & anterior eye : the journal of the British Contact Lens Association.

[5]  R. Beuerman,et al.  Elevated expression of matrix metalloproteinase-9 and inflammatory cytokines in keratoconus patients is inhibited by cyclosporine A. , 2015, Investigative ophthalmology & visual science.

[6]  R. Sorkhabi,et al.  Tear film inflammatory mediators in patients with keratoconus , 2015, International Ophthalmology.

[7]  A E Davidson,et al.  The pathogenesis of keratoconus , 2014, Eye.

[8]  G. Petrovski,et al.  Association between Mediators in the Tear Fluid and the Severity of Keratoconus , 2013, Ophthalmic Research.

[9]  S. Basu,et al.  Keratoconus: current perspectives , 2013, Clinical ophthalmology.

[10]  M. Oray,et al.  Tear Cytokine Levels in Vernal Keratoconjunctivitis: The Effect of Topical 0.05% Cyclosporine A Therapy , 2013, Cornea.

[11]  Yasin Cinar,et al.  Effects of vernal and allergic conjunctivitis on severity of keratoconus. , 2013, International journal of ophthalmology.

[12]  M. Willcox,et al.  Effects of eye rubbing on the levels of protease, protease activity and cytokines in tears: relevance in keratoconus , 2013, Clinical & experimental optometry.

[13]  C. McGhee,et al.  Computerized corneal tomography and associated features in a large New Zealand keratoconic population , 2011, Journal of cataract and refractive surgery.

[14]  J. Nichols,et al.  Tear proteomics in keratoconus , 2010, Molecular vision.

[15]  R. Kizek,et al.  Matrix metalloproteinases. , 2010, Current medicinal chemistry.

[16]  I. Offiah,et al.  Immune mechanisms in allergic eye diseases: what is new? , 2009, Current opinion in allergy and clinical immunology.

[17]  C. McMonnies.  Mechanisms of Rubbing-Related Corneal Trauma in Keratoconus , 2009, Cornea.

[18]  J. Shoji,et al.  Evaluation of eotaxin-1, -2, and -3 protein production and messenger RNA expression in patients with vernal keratoconjunctivitis , 2009, Japanese Journal of Ophthalmology.

[19]  C. McGhee,et al.  The Dundee University Scottish Keratoconus study: demographics, corneal signs, associated diseases, and eye rubbing , 2008, Eye.

[20]  O. Yılmaz,et al.  Evaluation of the Corneal Topographic Characteristics of Keratoconus With Orbscan II in Patients With and Without Atopy , 2007, Cornea.

[21]  H. Zhan,et al.  Multiple cytokines in human tear specimens in seasonal and chronic allergic eye disease and in conjunctival fibroblast cultures , 2006, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[22]  I. Lema,et al.  Inflammatory molecules in the tears of patients with keratoconus. , 2005, Ophthalmology.

[23]  S. Eperon,et al.  Eotaxin-1 (CCL11) up-regulation in tears during seasonal allergic conjunctivitis , 2004, Graefe's Archive for Clinical and Experimental Ophthalmology.

[24]  J. Gottsch,et al.  A randomized trial of topical cyclosporin 0.05% in topical steroid-resistant atopic keratoconjunctivitis. , 2004, Ophthalmology.

[25]  C. McMonnies,et al.  Keratoconus, allergy, itch, eye‐rubbing and hand‐dominance , 2003, Clinical and experimental optometry.

[26]  Donald J. Brown,et al.  The cascade hypothesis of keratoconus. , 2003, Contact lens & anterior eye : the journal of the British Contact Lens Association.

[27]  M. Irkec,et al.  Epithelial cells in ocular allergy , 2003, Current allergy and asthma reports.

[28]  P. Jose,et al.  Tear and mucus eotaxin-1 and eotaxin-2 in allergic keratoconjunctivitis. , 2003, Ophthalmology.

[29]  W. Hodge,et al.  Atopy and keratoconus: a multivariate analysis , 2000, The British journal of ophthalmology.

[30]  K. Tsubota,et al.  IL-4 Induces Eotaxin Production in Corneal Keratocytes but Not in Epithelial Cells , 2000, International Archives of Allergy and Immunology.

[31]  J. Woessner,et al.  Matrix Metalloproteinases* , 1999, The Journal of Biological Chemistry.

[32]  K. Tsubota,et al.  Presence of eotaxin in tears of patients with atopic keratoconjunctivitis with severe corneal damage. , 1999, The Journal of allergy and clinical immunology.

[33]  M. Baggiolini,et al.  Eotaxin-2, a Novel CC Chemokine that Is Selective for the Chemokine Receptor CCR3, and Acts Like Eotaxin on Human Eosinophil and Basophil Leukocytes , 1997, The Journal of experimental medicine.

[34]  G. Gleich,et al.  Effects of eosinophil granule proteins on human corneal epithelial cell viability and morphology. , 1997, Investigative ophthalmology & visual science.

[35]  W Newman,et al.  Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. , 1996, The Journal of clinical investigation.

[36]  M. Kenney,et al.  Increased Gelatinolytic Activity in Keratoconus Keratocyte Cultures: A Correlation to an Altered Matrix Metalloproteinase-2/Tissue Inhibitor of Metalloproteinase Ratio , 1994, Cornea.